https://www.statcounter.com/counter/counter.js
Web Analytics
Home » Posts tagged with » Cablivi
Ablynx wins Cablivi FDA approval for rare blood clotting disorder

Ablynx wins Cablivi FDA approval for rare blood clotting disorder

Cablivi FDA approval : Belgian biopharma company Ablynx has bagged approval from the US Food and Drug Administration (FDA) for its anti-vWF nanobody Cablivi (caplacizumab-yhdp) injection in combination with plasma exchange and immunosuppressive therapy for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP). According to the FDA, aTTP is a rare blood clotting disorder in […]